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Subclinical hypothyroidism in obese Turkish adolescents: the
relationship with anthropometry and fatty liver
Şamil HIZLI1, Nur ARSLAN2, Ayhan ABACI3, Benal BÜYÜKGEBİZ4

Aim: To evaluate whether subclinical hypothyroidism (SH) is associated with anthropometry and fatty infiltration of
liver in obese adolescents.
Materials and methods: The adolescents attended with the complaint of obesity aged 11 to 15 years included in the
study. Patients were diagnosed as obese adolescents with fatty liver. Age-, gender-, and body weight-matched obese
adolescents without fatty liver seen during the same period served as controls. Clinical characteristics, laboratory
parameters, and frequency of subclinical hypothyroidism (SH) of both groups were compared.
Results: The study population included 218 adolescents with obesity. Of 218, 30 (13.7%) had fatty liver at ultrasonography
(group 1) and the remaining 188 obese adolescents did not have fatty liver and served as control (group 2). The mean
ages of groups 1 and 2 were 12.7 ± 1.25 and 13 ± 1.39 years; the rate of female participants were 43.3% and 55.8%; and,
weight:height ratios were 157.2 ± 24 and 151.3 ± 19.8 (P = 0.37, 0.24, and 0.54, respectively). The prevalence of SH in
patients with fatty liver was 10% and was not significantly higher compared to the controls (6.4%, P = 0.55).
Conclusions: SH seems to be a secondary condition rather than a triggering factor for development of fatty liver in
adolescent obese patients. There was no statistically significant relation between subclinical hypothyroidism and fatty liver.
Key words: Adolescent, anthropometry, fatty infiltration of liver, obesity, subclinical hypothyroidism

Obez Türk adolesan çocuklarda subklinik hipotiroidi: antropometri ve nonalkolik
yağlı karaciğer hastalığı ile ilişkisi
Amaç: Bu çalışmanın amacı obez adolesanlarda subklinik hipotiroidi ile antropometri ve yağlı karaciğerin ilişkisinin
belirlenmesi.
Yöntem ve gereç: Obezite nedeniyle başvuran 11-15 yaşlarındaki adölesanlar çalışmaya alındı. Vakalar ultrasonografide
yağlı karaciğer saptanan adölesanlar olarak tanımlandı. Yaş cinsiyet ve vücut ağırlığı açısından farklılık göstermeyen
obez adölesanlar kontrol grubu olarak belirlerlendi. Klinik bulgular, laboratuar bulguları ve subklinik hipotiroidi(SH)
sıklığı karşılaştırıldı.
Bulgular: Çalışmaya toplam 218 obez adölesan alındı. Ultrasonografide yağlı karaciğer saptanan 30 adölesan; çalışma
grubu (Grup 1) diğer adölesanlar (n = 188) kontrol grubu (Grup 2) olarak gruplandı. Grup 1 ve 2 nin yaş, cinsiyet, ve
boya göre ağırlık ortalamaları farklı değildi (sırasıyla 12,7 ± 1,25 ve 13 ± 1,39 yıl, kızların oranı % 43,3 ve % 55,8; 157,2
± 24 ve 151,3 ± 19,8, P = 0,37, 0,24 ve 0,54) idi. Grup 1 deki adölesanlarda SH sıklığı % 10, kontrol grubunda ise % 6,4
(P = 0,55) olarak saptandı.
Sonuç: Yağlı karaciğeri olan obez adölesanlarda SH sıklığı kontrol grubuna oranla yüksek saptanmamıştır. Bu çalışmanın
sonuçları SH’nin yağlı karaciğer hastalığını tetikleyici olmaktan ziyade yağlı karaciğere sekonder bir durum olduğunu
düşündürmüştür.
Anahtar sözcükler: Obezite, insulin rezistansı, nonalkolik yağlı karaciğer hastalığı, hepatik arter rezistif indeksi, adölesan
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Introduction

of SH of both groups were compared.

Obesity and its complication nonalcoholic fatty
liver disease (NAFLD) continue to increase
dramatically among adolescents (1). NAFLD is a
spectrum of pathology ranging from fatty liver to the
most severe form, called nonalcoholic steatohepatitis
(NASH). NASH was found to be related with overt
hypothyroidism in adults (2). SH is a preliminary
stage of overt hypothyroidism, defined as a mild
elevation of thyroid-stimulating hormone (TSH) level
in patient with normal serum thyroxine level. In
adults, SH has been found to be associated with
hyperlipidemia (3,4), insulin resistance (5), and
obesity (6). To the best of our knowledge, no study so
far has compared the thyroid function of healthy
obese children with fatty liver to appropriate controls.
Therefore, our study was performed to investigate the
frequency of elevated TSH levels in obese children
with fatty liver and to search whether SH is associated
with fatty liver as well as body composition and
biochemical findings in obese adolescent patients.

Biochemical tests of the patients were performed
after a 12-h fasting period. Fasting serum glucose,
alanine
aminotransferase
(ALT),
aspartate
aminotransferase
(AST),
gamma
glutamyl
transpeptidase (GGT), total cholesterol (TC), highdensity lipoprotein cholesterol (HDL-C), low-density
lipoprotein cholesterol (LDL-C), triglycerides (TG),
total triiodothyronine (TT3), total thyroxine (TT4),
and thyroid stimulating hormone (TSH) levels were
measured. The thyroid stimulating hormone test was
used for comparison purposes since it is the most
commonly used test in diagnosis of hypothyroidism
in children at early ages (8). Normal ranges of TT3,
TT4, and TSH for 11-15 years age group were
accepted as 1.09-2.95 nmol/L, 5.36-11.5 μg/dL, and
0.5-4.4 mU/L, respectively (9). Subclinical
hypothyroidism is defined as the elevation of TSH
level over 4.4 mU/L along with normal TT3 and TT4
levels. ALT and AST normal limits were 5-45 U/L
(10). Total protein, albumin, total bilirubin, and
prothrombin time were tested if the patients’ ALT and
AST levels were above the accepted values. Serologies
of hepatotropic viruses and TORCH infection, serum
copper and ceruloplasmin levels, serum alpha 1-

Materials and methods
Case notes of 550 adolescents who were admitted
to the Pediatric Gastroenterology Hepatology Clinics
of Dokuz Eylül University Hospital from 1 January
1999 to 1 January 2006 with the complaint of obesity
(defined as a weight:height ratio above 120) were
examined. Of 550 patients, 1 patient with Cushing
Syndrome, 26 patients using steroid, 15 patients with
familial hyperlipidemia, 6 patients with growth
hormone deficiency, 4 patients with diabetes, and 1
patient with complete gonadal dysgenesis were
excluded. Patients with liver disease and who use
lithium,
amiodarone,
metoclopramide,
or
domperidone were not included in the study. Of
remaining 497 patients, 218 were (11-15 years old)
enrolled in the study (Figure 1). Cases were defined
as obese adolescents with fatty liver. Age-, gender-,
and body mass index-matched obese adolescents
without fatty liver at ultrasonography (US) seen
during the same period were examined as controls.
Physical examination findings and anthropometric
measurements of all the patients were recorded.
Weight:height ratios (W:H%) of the patients were
calculated according to CDC charts (7). Clinical
characteristics, biochemical findings, and frequency
288
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Figure 1. Characteristics of the study group.
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antitrypsin level, and autoantibodies against nuclear,
smooth muscle, liver, and kidney microsomal type-1
antigens were screened to eliminate infectious,
metabolic, and immunologic liver pathologies.
Fatty liver was diagnosed by US. Three
ultrasonographic criterias were used to confirm the
fatty liver diagnosis (11,12). For each criterion, a score
was assigned as an indicator of the level of fatty
infiltration. A score of 2 (++) indicated a definitive
positive finding of fatty infiltration. A score of one (+)
indicated a probable fatty infiltration. When the fatty
infiltration was negative (-), a score of zero was
assigned. The sum of the scores for the 3 criteria was
considered to be an indicator of the severity of fatty
infiltration. Thus, the fatty liver indicator ranged from
0 to 6, where a total score of 3 or more was considered
as an indication of fatty liver. The criteria and scoring
assignments are described below.
1. The echo levels for the liver and kidney
parenchyma were compared. An evaluation was made
of the relative increase in the liver versus kidney
surface echo level accompanied by a high contrast
between liver and kidney parenchyma (liver-kidney
echo discrepancy). A large discrepancy between
hepatic and renal echoes resulted in a (++) finding. A
slight increase in the liver echogenecity, which is a
slight increase of liver and kidney echo discrepancy,
was assigned a (+) evaluation. A negative (-)
evaluation of fatty liver was made when the echo level
was homogeneous and the contrast between the liver
and the kidney parenchyma was unclear.
2. An assessment was made of echo penetration
into the deep portion of the liver. Penetration of
ultrasonography at the deepest portion of the liver is
low due to the interference of the enhanced liver
surface echogenecity, which results in the opacity of
the lower part of the liver and the loss of visibility of
the diaphragm. A (++) evaluation was given when
both indicators were definitely present. The probable
presence of both indicators resulted in a (+) score,
while a (-) evaluation meant that the liver structure
was clearly defined from the surface of the liver to the
diaphragm.
3. The clarity of the hepatic vessels in the
sonograph, especially the veins, was evaluated. When
hepatic vessel structures were not clear and the

identification of the vessel walls could not be made, a
(++) evaluation was assigned. If loss of echoes from
the vessel wall was observed, a (+) score was given. A
(-) score resulted when the vessel structures and vessel
walls could be clearly defined.
Data were analyzed by SPSS 11.0. The chi-square
and Fisher’s exact tests were used for comparing group
ratios and Student’s t test was used for comparing
group averages. A P value less than 0.05 was
considered significant. Power of the study for
comparison of subclinical hypothyroidism frequency
was calculated as 21.3.
Results
Table 1 shows the anthropometric, physical, and
biochemical parameters of both groups. The study
population consists of 218 adolescents with obesity.
Thirty (13.7%) of them had fatty liver at
ultrasonography (study group, group 1) and
remaining 188 (86.3%) obese adolescents without
fatty liver served as control (group 2). Data regarding
age, gender, and weight:height ratios were similar in
both groups. The mean ages of groups 1 and 2 were
12.7 ± 1.25 and 13.0 ± 1.39 years; the rate of female
participants were 43.3% and 55.8%, and weight:height
ratios were 157.2 ± 24 and 151.3 ± 19.8, respectively
(Table 1). The mean fasting serum glucose levels of
groups 1 and 2 were similar at admission. Mean ALT
level of group 1 was higher than that of group 2 (P <
0.0001). Mean AST levels of groups 1 and 2 were
similar. Mean GGT level of group 1 was higher than
that of group 2 (P = 0.028). Mean LDL-C and TG
levels of group 1 were all higher compared to group 2
(P = 0.03, P = 0.007, respectively). Mean total T3, total
T4, and TSH levels of both groups were similar (P =
0.18, P = 0.55, P = 0.36, respectively). The prevalence
of SH in patients with fatty liver was 10% and was not
significantly higher compared to the control group
(6.4%, P = 0.55).
Discussion
The purpose of this study was to find out whether
SH is a triggering factor for fatty liver and our findings
support the idea that thyroid hormone abnormalities
associated with fatty liver are secondary. There was no
289

Subclinical hypothyroidism in obese Turkish adolescents: the relationship with anthropometry and fatty liver

Table 1. Demographic, physical, and biochemical parameters of the patients with fatty liver
(group 1) and the patients with normal liver echogenecity based on US (group 2).
Mean ± SD (range)

Age (year)
Gender (F / M) (n)
Weight for height (%)
Serum glucose (mg/dL)
ALT (U/L)
AST (U/L)
GGT (U/L)
TC (mg/dL)
HDL-C (mg/dL)
LDL-C (mg/dL)
TG (mg/dL)
TT3 (nmol/L)
TT4 (μg/dL)
TSH (mU/L)
SH (n,%)

Group 1
n = 30

Group 2
n = 188

12.7 ± 1.25 (11-15)
13 / 17
157.2 ± 24 (126-234)
93.8 ± 12.6 (74-136)
33.7 ± 36 (10-190)
25.1 ± 13.9 (11-77)
21.8 ± 12.8 (9-74)
174.8 ± 27.3 (134-247)
43.6 ± 8 (30-67)
111.9 ± 45.3 (68-304)
121.4 ± 42.3 (52-328)
1.6 ± 0.45 (1-3.5)
8.2 ± 2.3 (1.35-11.7)
2.66 ± 1 (1.2-4.9)
3 (10%)

13 ± 1.39 (11-15)
105 / 83
151.3 ± 19.8 (118-229)
92.9 ± 9 (68-120)
20.8 ± 6.5 (10-40)
22.7 ± 11.6 (10-147)
15.6 ± 8.3 (7-80)
167.3 ± 26.2 (117-234)
48 ± 9.7 (26-78)
100.7 ± 21.5 (60-157)
99.3 ± 40.7 (40-337)
1.56 ± 0.29 (1-2.8)
8.4 ± 1.7 (4-16.4)
2.48 ± 1.14 (0.7-5.95)
13 (6.4%)

P
value*

NS
NS
NS
NS
<0.0001
NS
0.028
NS
0.019
0.030
0.007
NS
NS
NS
NS

*NS: Not significant

difference between groups 1 and 2 in terms of the
frequency of SH, which gives the idea that SH is
secondary to fatty liver and supports the idea that
treatment with thyroxine would not help in protecting
adolescents from fatty liver development. The
prevalence of SH was 7.3% in all participants, which
confirmed the finding of Stichell et al., 7.5% SH
prevalence in obese adolescents (6). In this study,
increased liver echogenecity resembling fatty liver at
US images was observed in 13.7% of the patients.
Prevalence of fatty liver was reported as 12% in a
previous study (11).
The gold standard tool for the diagnosis of fatty
liver is liver biopsy. However, liver biopsy is invasive
and costly. Although imaging techniques have been
helpful in assessing non-alcoholic fatty liver and
steatosis, they lack the ability to identify fibrosis (12).
Therefore, liver biopsy is preferred for the follow up of
drug treatment patency and the detection of cirrhosis.
On the other hand, US is recommended for the
diagnosis of steatosis (1,13). Magnetic resonance
imaging and US were used in some previous pediatric
290

studies for diagnosis of fatty liver (12,14). In the
present retrospective study, the assessment of the fatty
liver was performed using US as recommended in the
literature (12-14).
Fatty liver results from the accumulation of fatty
acids in various forms, predominantly triglycerides
(15,16). Our group 1 patients’ lipid profiles were in
favor of lipogenesis since triglycerides were
significantly higher in this group compared to the
control group. This can occur when the amount of
fatty acid supplied to the liver from the gut or
adipose tissue exceeds the amount needed for
mitochondrial oxidation, phospholipid, and
cholesterol ester synthesis (17). Also in
hyperinsulinemia, fatty acids are esterified to
triglycerides. Thus, the conjunction of high free fatty
acid and insulin resistance, both directly related to
increased visceral fat mass, play important
complementary roles for the development of liver
steatosis (18). Furthermore, the development of fatty
liver may increase insulin clearance, which can
initiate a vicious circle (19).
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It has been suggested that increased hepatic
oxidative stress, perhaps on hepatic mitochondria,
causing their dysfunction (20,21). As a result
mitochondria consume more oxygen but produce less
ATP than usual. The increase in oxidative stress may
arise from increased insulin resistance, increased free
fatty acid metabolism, increased endotoxin levels in
the liver, increased activity of cytochrome p-450 2E1,
increased iron stores, and/or decreased antioxidant
activities (22). Oxidative stress increases hepatic
steatosis via lipid peroxidation increase and released
cytokines lead to more mitochondrial damage.
Mitochondrial injury can lead to mutation and loss of
mitochondrial DNA. Mitochondrial DNA damage or
loss was shown in nucleoside hepatotoxicity, alcohol
consumption, aging, and Wilson disease (23). Since
adenosine triphosphate (ATP) is critical for
maintaining cellular integrity, its depletion may
predispose to hepatocellular injury. Depletion of
hepatic ATP levels was observed and the magnitude of
this depletion was correlated with body mass index in
a previous study (24). Mitochondrial ATP is a source
of cyclic AMP, which is a second messenger for lots of
hormones including TSH and TRH. With the
depletion of ATP, the production of the second
messenger c-AMP by adenylate cyclase decreases.
Liver cells are one of the main targets of thyroid
hormones and in case of the depletion of cyclic AMP,
their action in hepatocytes would be affected. The
clinical result is hepatocyte unresponsiveness to
thyroid hormones and TSH level increases in order to
overcome this decrease.
Support for the hypothesis that increased lipid
levels together with lipid peroxidation, and decreased

antioxidant defense in hypothyroidism has been
reported before and also hypothyroidism has been
found significantly related with insulin resistance
(22,25). In a study by Rapa et al., it was shown that
there is a wide range of clinical, biochemical, and
genetic factors involved in pediatric subclinical
hypothyroidism pathogenesis (26).
In the adult literature, it has been reported that
higher levels of AST, ALT, and GGT likely reflect
NAFLD (27-29). Results of the present study confirm
that serum ALT and GGT levels of children with fatty
liver are higher (30). There is a need for detailed
studies regarding the relation of ALT and GGT with
fatty liver in children.
Several limitations of this study should be
considered. Since it is a retrospective study,
ultrasonographic examinations were not performed
using the same machine by the same radiologist. We
were not able to compare insulin levels and investigate
its relation with SH, since we did not have insulin
measurement records of most children in the study.
Another limitation is the power of the study (21.3).
Since this is the first study on this topic and it is a
retrospective study, we were not able to make power
analysis before the study.
In conclusion, SH frequency in obese children
with fatty liver is not higher than that in patients
without fatty liver, which suggests that SH seems to
be a result of fatty liver development. Further studies
with a higher power to determine the cause and effect
relationship between fatty liver, subclinical
hypothyroidism, ALT, and GGT levels in obese
adolescents are warranted.
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